Literature DB >> 9490415

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.

L L Lanier1, B C Corliss, J Wu, C Leong, J H Phillips.   

Abstract

Natural killer (NK) cells express cell-surface receptors of the immunoglobulin and C-type lectin superfamilies that recognize major histocompatibility complex (MHC) class I peptides and inhibit NK-cell-mediated cytotoxicity. These inhibitory receptors possess ITIM sequences (for immunoreceptor tyrosine-based inhibitory motifs) in their cytoplasmic domains that recruit SH2-domain-containing protein tyrosine phosphatases, resulting in inactivation of NK cells. Certain isoforms of these NK-cell receptors lack ITIM sequences and it has been proposed that these 'non-inhibitory' receptors may activate, rather than inhibit, NK cells. Here we show that DAP12, a disulphide-bonded homodimer containing an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain, non-covalently associates with membrane glycoproteins of the killer-cell inhibitory receptor (KIR) family without an ITIM in their cytoplasmic domain. Crosslinking of KIR-DAP12 complexes results in cellular activation, as demonstrated by tyrosine phosphorylation of cellular proteins and upregulation of early-activation antigens. Phosphorylated DAP12 peptides bind ZAP-70 and Syk protein tyrosine kinases, suggesting that the activation pathway is similar to that of the T- and B-cell antigen receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490415     DOI: 10.1038/35642

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  240 in total

1.  Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.

Authors:  J Munday; S Kerr; J Ni; A L Cornish; J Q Zhang; G Nicoll; H Floyd; M G Mattei; P Moore; D Liu; P R Crocker
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 2.  Studies of the humoral immune response.

Authors:  G Kelsoe
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Transmembrane T-cell receptor peptides inhibit B- and natural killer-cell function.

Authors:  Nghi T Huynh; Rosemary A Ffrench; Ross A Boadle; Nicholas Manolios
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

Review 4.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

Review 5.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

6.  The tandem Src homology 2 domain of the Syk kinase: a molecular device that adapts to interphosphotyrosine distances.

Authors:  Sangaralingam Kumaran; Richard A Grucza; Gabriel Waksman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis.

Authors:  H Jiang; S Curran; E Ruiz-Vazquez; B Liang; R Winchester; L Chess
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-24       Impact factor: 11.205

Review 8.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

9.  Structural characteristics of zebrafish orthologs of adaptor molecules that associate with transmembrane immune receptors.

Authors:  Jeffrey A Yoder; Timothy M Orcutt; David Traver; Gary W Litman
Journal:  Gene       Date:  2007-07-27       Impact factor: 3.688

10.  Induction of myelodysplasia by myeloid-derived suppressor cells.

Authors:  Xianghong Chen; Erika A Eksioglu; Junmin Zhou; Ling Zhang; Julie Djeu; Nicole Fortenbery; Pearlie Epling-Burnette; Sandra Van Bijnen; Harry Dolstra; John Cannon; Je-in Youn; Sarah S Donatelli; Dahui Qin; Theo De Witte; Jianguo Tao; Huaquan Wang; Pingyan Cheng; Dmitry I Gabrilovich; Alan List; Sheng Wei
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.